VOLUME 6 , ISSUE 1 ( January-April, 2021 ) > List of Articles
Manu Jain, Puneet Rijhwani, Anchin Kalia, Dinesh Yadav, Ambika Tyagi
Keywords : COVID-19, Diabetes, Mucormycosis
Citation Information : Jain M, Rijhwani P, Kalia A, Yadav D, Tyagi A. Mucormycosis: A Deadly Complication of COVID-19 and Diabetes. J Mahatma Gandhi Univ Med Sci Tech 2021; 6 (1):35-38.
DOI: 10.5005/jp-journals-10057-0149
License: CC BY-NC 4.0
Published Online: 31-08-2021
Copyright Statement: Copyright © 2021; The Author(s).
Mucormycosis is a fungal infection, caused by fungi of the order Mucorales of subphylum Mucoromycotina. It is an aggressive, life-threatening infection that is common in immunocompromised patients and diabetics. COVID-19 infection and its treatment renders the patient severely immunocompromised and can increase the risk of such secondary infections. Here, we present a case of a 62-year-old man, a known case of diabetes who was recently diagnosed as COVID-19 positive. He then complained of left eye swelling and pain, with chemosis while being on steroids and remdesivir for the COVID-19 pneumonia. He was later diagnosed with orbital cellulitis, with a possible fungal infection which was later confirmed microbiologically. The patient was started on liposomal amphotericin B and high-grade antibiotics for orbital cellulitis. The patient later succumbed to sepsis-related complications. We conclude that prompt identification of symptoms and early initiation of therapy is necessary to have a better outcome in such cases, also this case can help us be more vigilant in diabetic patients with COVID-19, in whom therapeutic agents like steroids and monoclonal antibodies should be given at lowest recommended doses.
© Jaypee Brothers Medical Publishers (P) LTD.
We use cookies on this site to enhance your user experience.
By clicking any link on this page you are giving your consent for us to set cookies.